Intellia Therapeutics, Inc.

NTLA·NasdaqGM
Compare
13.07+0.47 (+3.73%)today
At close: Oct 9, 4:00 PM EDT · Real-time · USD
After hours13.03−0.04 (−0.31%)Oct 9, 7:54 PM EDT

Real-time prices from Yahoo Finance's public feed. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close12.60
Open12.39
Day range11.9413.27
52-week range7.9528.25
Volume8.14M
Avg. volume (3M)4.29M
Market cap1.83B
P/E ratio (TTM)—
Forward P/E-5.09
EPS (TTM)-3.35
Dividend yield—
Beta (5Y)—
Shares outstanding140.13M
Earnings dateAug 6, 2026 (est.)
Analyst target—
Profit margin—

Latest news

All NTLA news ›
Defense World·Upbeat

Intellia Therapeutics (NASDAQ:NTLA) Upgraded at Barclays

Intellia Therapeutics (NASDAQ:NTLA – Get Free Report) was upgraded by investment analysts at Barclays to a “strong sell” rating in a report released on Tuesday, Marketbeat.com reports. The brokerage currently has a $8.00 price objective on…

The Globe and Mail·Downbeat

Lunai Bioworks Seeks Nasdaq Trading Suspension Amid Probe

Lunai Bioworks ( (LNAI) ) has issued an update. More about Lunai Bioworks Lunai Bioworks, Inc. is a biotechnology company whose common stock is listed on Nasdaq, giving it exposure to public equity markets and to trading practices…

Markets Daily·Upbeat

Mobilicom Limited (NASDAQ:MOBBW) Stock Short Interest Jumps 437.0%

Posted by Tristan Rich on Oct 10th, 2026 Mobilicom Limited (NASDAQ:MOBBW – Get Free Report) was the target of a large increase in short interest in the month of September. As of September 30th, there was short interest totaling 8,678…

From articles in the 4Search news index.

In the news

98mentions in 30 days
12with it in the headline
Upbeatheadline tone

Measured across the 4Search news index. Headline tone is a simple word-based reading of the latest 98 headlines, not a forecast.

Market data is provided for information only and comes from free public sources. Quotes are marked real-time or delayed as their source reports them; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.